drugset / Trial / NCT01741974

Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

NCT01741974 ↗

Phase 3 Completed 340 enrolled Institute for Atherosclerosis Research, Russia
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to investigate the anti-atherosclerotic and anti-climacteric action of natural drug Karinat based on phytoestrogen-rich botanicals in perimenopausal women.

Timeline

Start
2005-10
Primary completion
2012-06
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Karinat Traditional medicine (herbal / TCM) 500 mg Oral

Indications